Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin C (*UBC*) is a gene that encodes a polyubiquitin precursor protein comprising tandem repeats of the highly conserved ubiquitin monomer. Upon cellular stress such as heat shock, oxidative stress, and proteotoxic insults, UBC transcription is upregulated to maintain ubiquitin homeostasis and facilitate the removal of damaged or misfolded proteins. Polyubiquitin chains formed from ubiquitin C serve non-redundant cellular functions depending on linkage type, including targeting proteins for proteasomal degradation, regulating DNA repair, controlling cell cycle progression, mediating kinase signaling, and organizing autophagy or innate immune responses. Loss of UBC function results in developmental failure, demonstrating its essential role in cellular viability and stress adaptation. While ubiquitin and its conjugation pathway are central to many diseases and therapeutic strategies, UBC itself is not typically targeted by drugs, with therapies focusing on downstream proteasome activities or ubiquitin pathway enzymes
Drugs such as proteasome inhibitors block the degradation of ubiquitinated proteins. Modulators of protein homeostasis impact the ubiquitination pathway indirectly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin C (UBC).